Product NDC: | 0641-0121 |
Proprietary Name: | Hydromorphone Hydrochloride |
Non Proprietary Name: | Hydromorphone Hydrochloride |
Active Ingredient(s): | 2 mg/mL & nbsp; Hydromorphone Hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0641-0121 |
Labeler Name: | West-ward Pharmaceutical Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 19720101 |
Package NDC: | 0641-0121-25 |
Package Description: | 25 VIAL in 1 CARTON (0641-0121-25) > 1 mL in 1 VIAL (0641-0121-21) |
NDC Code | 0641-0121-25 |
Proprietary Name | Hydromorphone Hydrochloride |
Package Description | 25 VIAL in 1 CARTON (0641-0121-25) > 1 mL in 1 VIAL (0641-0121-21) |
Product NDC | 0641-0121 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydromorphone Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 19720101 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | West-ward Pharmaceutical Corp. |
Substance Name | HYDROMORPHONE HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |